AVR – Anteris Technologies Ltd


Subscribe for full access

Unlock Industry-grade Shariah Compliance for US, UK, Canada, Germany, GCC, Europe and India. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $3.99/month


1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL

Total Analysts: 0

Company Profile

Anteris Technologies Ltd is an Australia-based structural heart company engaged in developing technologies solutions that help healthcare professionals. The Company’s segments include Operations and Projects. The Operation segment provides Bio implant ADAPT operations inclusive of manufacturing and sales. The Project segment includes Transcatheter Aortic Valve Replacement (TAVR), which is developed using ADAPT 3D single-piece technology and other development projects across the Company. It offers two products, ADAPT and DurAVR. ADAPT technology is a BioScaffold that re-engineers xenograft tissue into a pure collagen scaffold with optimized strength and pliability, biocompatibility and durability. DurAVR heart valve Is focused on delivering a functional cure in the treatment of Severe Aortic Stenosis.

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan